A poll released this week by the Virginia Interfaith Center, a member of the Virginians for Paid Sick Days Coalition, found that a whopping 88% of Virginians support a requirement that employers provide paid sick leave to their workers. Specifically, the poll asked...
Under a plan announced Thursday, the government would consider overriding the patent for high-priced drugs that have been developed with the help of taxpayer money and letting competitors make them in hopes of driving down the cost.
November’s General Assembly elections will likely have a meaningful impact on how much Virginians spend for prescription medication. Via both words and actions, Republicans and Democrats are demonstrating which side of prescription drug affordability they’re on. In...
Elections have consequences, and one of the groups most keenly aware of this fact are big special interest groups – among them, the Pharmaceutical Research & Manufacturers of America (aka PhRMA). After benefiting from Republican control of the governorship and...
The provision, signed into law by President Biden, will significantly lower out-of-pocket drug costs for many of the nearly 1.1 million Virginia seniors enrolled in Medicare Part D coverage.
The COVID-19 booster is now available, and provides better protection against currently circulating variants of the illness.
The 988 Suicide & Crisis Lifeline has added American Sign Language (ASL) to their services nationwide.
Starting in 2026, the prices for these drugs will decrease for up to nine million seniors, thanks to a provision in President Biden’s Inflation Reduction Act that allows Medicare to negotiate the prices for these drugs directly with the manufacturers.
The law ensured that 63,000 Virginians were able to keep their health insurance, reduced the cost of insulin for over 36,000 seniors, and incentivized several manufacturers to invest in the state and create more clean energy jobs.
Short-term plans offer limited coverage, can deny coverage based on pre-existing conditions, and trick consumers into buying products that provide “little or no coverage when they need it most."
